Lingraphica, Inc.

Lingraphica manufactures augmentative and alternative communication (AAC) devices and software for individuals with speech and language disorders. The company offers three primary AAC device lines—TouchTalk Plus (large-screen), TouchTalk (compact), and MiniTalk (ultra-portable)—designed for users with aphasia, apraxia, dysarthria, autism, Parkinson's disease, stroke, brain injury, primary progressive aphasia (PPA), and other neurological conditions. All devices are Medicare-reimbursable and covered by Medicaid, commercial insurance, and VA benefits. Lingraphica also provides complementary therapy applications including TalkPath Therapy (speech and language exercises), TalkPath News (reading comprehension practice), and SmallTalk (quick-access phrases and videos). The company offers free device trials, one-on-one clinical support for speech-language pathologists (SLPs), continuing education with ASHA CEUs, and comprehensive customer support. Founded 35 years ago, Lingraphica serves device users, caregivers, families, and clinical professionals across home, school, therapy, and acute-care settings. The company emphasizes customizable interfaces, ease of use, lifetime support, and integration with SLP-driven therapy protocols.